Transcatheter hepatic arterial chemoembolization using emulsions composed of anticancer agents and gelatin sponges (GS) has been an efficient and safe palliative treatment for inoperable hepatocellular carcinoma (HCC). We employed catheter-mediated left hepatic arterial embolization (CHAE) to increase transduction efficiency of adenoviral vector in canine hepatocytes. The emulsion was prepared by mixing pieces of GSP and adenoviral vectors expressing recombinant b-galactosidase (Ad.LacZ) or human hepatocyte growth factor (Ad.hHGF). After the left hepatic artery was catheterized under angiography, CHAE with Ad.LacZ or Ad.hHGF was performed. Livers were removed and stained for LacZ activity on day 7. The expression pattern of LacZ staining was either scarce or patchy around the central hilum of the hepatic artery, or was homogeneously distributed in whole lobes, depending on whether large or small pieces of GSP were used. Hematological and serum biochemical changes during CHAE exhibited only a few effects. The chronological measurement of serum HGF concentration showed that the duration of transgene expression was greater after CHAE with Ad.hHGF. A similar pattern of transgene expression was observed in a rat model after hepatic arterial embolization with differential doses of Ad.hHGF soaked in GSP. These results suggest that hepatic arterial embolization by transcatheter mediated infusion with a mixture of adenovirus-GSP could be used for human HCC.
A denoviral vectors are particularly important candidates for the transient expression of therapeutic or cytotoxic genes, due to their ability to induce high and rapid transgene expression levels in hepatocytes. However, several studies have shown liver and immunological toxicities as a result of the intravenous administration of recombinant adenoviral vectors, as high doses of viral vectors are required to productively express the transgene. 1, 2 Although concerns regarding safety of adenoviral vectors may ultimately limit the breadth of their application, clinical data on the intratumoral injection of replication-selective oncolytic adenoviruses show superior efficacy in chemotherapy-resistant tumors when it is combined with chemotherapy, 3, 4 suggesting its clinical feasibility. However, clinical data on the hepatic arterial infusion of oncolytic adenovirus suggest that a new strategy should be established to achieve adequate levels of virus within tumors. 5, 6 Transcatheter hepatic arterial chemoembolization using emulsions of anticancer agents, iodized oil esters (IOE) and/or GSP has been determined to be an efficient and safe palliative treatment for inoperable hepatocellular carcinoma (HCC), offering prolonged survival and good life quality. 7, 8 As GSP induces embolization and is absorbed slowly, without inducing excessive inflammatory reaction or irritation, 8 anticancer agents soaked in GSP are released slowly into the liver environment. We asked whether adenoviral vectors, rather than anticancer drugs soaked in emulsion of GSP, might be released slowly after catheter-mediated embolization, a process that we hoped might increase transduction efficiency and/ or decrease viral clearance. As an artery specifically supplying HCC mass is selected in the clinical setting, arterial embolization by a mixture of oncolytic adenovirus and GSP might offer advantages.
Materials and methods

Recombinant adenoviral vectors
Recombinant b-galactosidase or hepatocyte growth factor (HGF) under the control of the cytomegalovirus promoter (Ad.LacZ or Ad.hHGF respectively) were produced as previously described.
9,10 Viral titer was measured by standard plaque assay using 293 cells.
Selection to the left hepatic artery of canine under angiographic guidance Domestic canines weighing 9.5-11 kg were used. The experimental protocol was approved by Dong-A Medical Center Committee on the Guide for the Care of Laboratory Animals. Inhalation anesthesia with 2% of isoflurane (Aerane s , Ilsung, Seoul, Korea) was applied after premedication with ketamine (20 mg/kg; Ketara s , Yuhan, Seoul, Korea) and xylazine (1.5 mg/kg; Rompun s , Bayer Korea, Kyunggi-Do, Korea). The femoral artery was catheterized with a 4F micropuncture needle kit s and introducing sheath (Cook Inc., Indianapolis, IN). Common hepatic angiography was performed using an 4F Cobra s catheter (Fig 1a) . The tip of a 3F S-P s microcatheter (Terumo, Tokyo, Japan) was then advanced to a position within the left hepatic artery by the coaxial method (Fig 1b) . A schematic illustration of the canine liver showing whole lobes is presented in Figure 1c to allow a comparison to be made with the common hepatic angiography shown in Figure 1a . From left to right, we designated the lobes as I-VII, that is, corresponding to I-VII of Figure 1a .
Adenovirus vector delivery by catheter-mediated left hepatic artery embolization (CHAE) in a canine
For production of GSP, two sheets of 20 Â 15 Â 7 mm Gelfoam (Gelfoam s , Pharmacia & Upjohn, Kalamzoo, MI) were cut into approximately 3 Â 2 Â 2 mm (large size) or 1 Â 1 Â 2 mm (small size) pieces. The sizes of the Gelfoam pieces were determined under a light microscope. The emulsion for CHAE was prepared by mixing 2 ml of Ad.LacZ (10 12 particles/ml) or Ad.hHGF (4 Â 10 12 particles/ml) in PBS with large-or small-sized GSP and 2 ml of Hexabrix 320 s (Ioxaglic acid, Guerbet Korea), which was included for angiography. CHAE was performed by careful infusion of emulsion after positioning the 3F microcatheter within the left hepatic artery (Fig  1d) . After CHAE, the catheter was flushed with 2 ml of normal saline. As a control study, 2 ml of Ad.LacZ in PBS (10 12 particle/ml) was mixed with 2 ml of Hexabrix 320 s (without GSP) for the catheter-mediated left hepatic arterial simple infusion (CHAS) technique.
Ad.hHGF soaked in GSP or in PBS delivery by rat hepatic arterial embolization
The Gelfoam (50 mg in 4 ml PBS/kg) was homogenized at submaximal speed by ''T25 Basic'' tissue homogenizer (IKA, LABORTECHNIK, Cincinnati, OH) for 2 min. After intraperitoneal injection of 50 mg/kg of sodium pentobarbital (Nembutal, Abbott Laboratories, North Chicago, IL), a midline laparotomy was performed in Sprague-Dawley rats (300-350 g). The liver was carefully retracted to expose the gastroduodenal artery, which was dissected and cannulated in a retrograde direction with Silastic tubing (Dow Corning, Midland, MI) measuring 0.012 inches in inside diameter by 0.250 inches in outside diameter. When the tip of tubing was placed before the bifurcation that led to the proper hepatic artery, the emulsion mixture composed of homogenized GSP and differential doses of Ad.hHGF was manually injected slowly, that is, for 1-2 minutes per 0.8 ml, using a 1 ml syringe.
Image analysis of b-galactosidase-stained cells
Each lobular segment of the canine liver was immediately frozen after killing on day 7 or 14 post Ad.LacZ delivery. After washing three times in PBS, fixed tissue was incubated overnight at 371C in X-Gal solution (Fisher, Pittsburgh, PA), which containing 1 mM MgCl 2 , 5 mM K 4 Fe(CN) 6 Á 3H 2 O and 5 mM (K 3 Fe(CN) 6 (Sigma, St Louis, MO) in PBS. b-Galactosidase-stained cells were assessed using image analysis techniques on X-Galstained histological slides (6 mm in thickness), by a planimetric method on an Automatic Image Analysis System (Carl Zeiss, Oberkochem, Germany). 
Analysis of serum
Blood was sampled (20 ml) from each canine on days 0, 1 and 7 after Ad. 
Statistical analysis
Data are expressed as means7SEM. Comparisons were made using the two-tailed Student's t-test, and significance was accepted for P-values of o.05.
Results and discussion
The intratumoral injection of oncolytic adenovirus has emerged as a promising approach for the treatment of tumors resistant to other modalities, 3, 4 but its intraarterial infusion warrants additional study. 5, 6 Anticancer drug delivery by hepatic arterial chemoembolization using GSP and/or IOE has been widely used in clinical settings to treat HCC efficiently, without significantly changing hepatic function due to the liver's duplex blood supply systems. 7, 8 Although it is not via blood vessel, an efficient and localized transgene expression has been successfully achieved using gelatin sponge sheets (GSS) in a rat Achilles tendon (for 17 days) and mouse cochlea. 11, 12 Taken these findings together, we hypothesized that catheter-mediated hepatic arterial embolization with GSP would enhance transgene expression efficiency into hepatocytes, because of the low clearance rate and long contact time of adenovirus soaked in GSP.
The size of GSP might be important for CHAE-mediated adenoviral vector delivery
In the first experiment of this study, we prepared large GSP (D3 Â 2 Â 2 mm) loaded with Ad.LacZ (2 Â 10 11 particles/kg) for the CHAE emulsion mixture. After 7 days of adenoviral vector delivery by CHAE, livers were removed and stained to test for LacZ activity. Tissue staining for LacZ was almost zero, although slight staining was present in the second lobe (Lobe II). However, the expression pattern of LacZ staining in Lobe II was patchy, and only in and around the central hilum (Fig 2a) . We speculate that the emulsion mixture containing large GSP was distributed around the central hilum and not to the more distal areas because of the size limitation imposed by blood vessel diameter. The LacZ staining appeared mainly in hepatocytes (hexagonal cells with a round nucleus) and rarely in Kupffer cells (slightly oval shaped-cells with a small nucleus), as determined by hematoxylin-eosin staining. Even though LacZ expression pattern was patchy, the expression of transgene into the hepatocytes was relatively high in localized areas.
In order to overcome this size limitation, we prepared small GSP (D2 Â 1 Â 1 mm) loaded with Ad.LacZ (2 Â 10 11 particles/kg) for the CHAE emulsion mixture. At 7 days after adenovirus vector delivery by CHAE, livers were removed and stained for LacZ activity. The LacZ staining was homogenous in individual lobes, regardless of the level of tissue section from the central hilum (''a'' level of Fig 1c) to the distal end of a lobe (''b'' level of Fig 1c) , which suggests that the size of GSP might be important for the even distribution of emulsion into the small blood vessels. Representative of LacZ staining in different lobes are presented in Figure 2b -g. The differential levels of LacZ staining in Lobes I-III (lobes to which blood is supplied by the left hepatic artery) are probably due to the differential structures of subdivisions of the left hepatic artery. Small but significant LacZ staining in Lobes IV-VII may be due to the collateral vascular system and/or backflow of emulsion during CHAE. A similar pattern of LacZ staining after adenoviral vector delivery by CHAE was observed during another experiment (Fig 2h, n ¼ 3) . Figure 2h shows that the sequence of levels of tissue staining for LacZ activity in the seven different lobes were II4III,I44VII4IV, V,VI.
GSP-mediated arterial infusion of adenoviral vector substantially augments transduction efficiency to hepatocytes with only a mild effect on liver function
As a control study (without GSP), Ad.LacZ (2 Â 10 11 particles/kg) were systemically administered by CHAS technique into two canines. At 7 days after delivery, livers were removed and stained for LacZ activity. The level of LacZ staining in different sections from whole lobes after simple infusion was almost zero (Fig 2i) . As the left hepatic arterial simple infusion of 2 Â 10 12 Ad.LacZ without GSP (CHAS) into a 10 kg canines might be subthreshold for transgene expression, 13 a high dose of Ad.LacZ in PBS (5 Â 10 11 particles/kg) inducing relatively high hepatotoxicity (241.2.4755 and 313.8745 for SGOT and SGPT, respectively, on day 3, n ¼ 2), was injected. Figure 2j shows that the transgene expression determined on day 7 post CHAS with 5 Â 10 11 particles/ kg was relatively abundant (6.372.2, n ¼ 4), but was much less than that on day 7 post CHAE with 2 Â 10 11 (Fig 2c, 61 .271.3, n ¼ 3) or 5 Â 10 11 particles/kg (Fig 2k,  61.2711.3, n ¼ 3) . Moreover, the transgene expression of local areas determined on day 14 post injection by CHAE with 5 Â 10 11 particles/kg was extremely abundant (Fig 2l,  m) although that on day 14 post CHAS with same dose was almost zero (data not shown). This suggests that adenovirus in unresolved localized GSP on day 14 post CHAE might be still functional, and might be responsible for the high level of transgene expression in local areas.
In order to determine systemic and hepatic toxicity during CHAE or CHAS, we measured hematological and serum biochemical changes. Platelet cell count (256.47 79.8 and 221.17102.2/ml on day 0 for CHAS and CHAE respectively) decreased on day 1 (210.9725.4 and 161.1733.2 for CHAS and CHAE, respectively), but normalized on day 3 and 7, which is a similar pattern to that found in monkeys. 12 However, the other results (Materials and methods) were not significantly altered. Serum biochemistry testing after adenoviral delivery by CHAE also showed relatively few effects except for a slight effect on liver function. Serum SGOT (147.5745.3 IU/l) and SGPT (124.9748.7 IU/l) values on day 1 in CHAE-treated canines were slightly higher than in CHAS-treated canines (81.279.3 and 75.17 10.2 IU/l for SGOT and SGTP, respectively), but normalized on day 3 and 7.
These results suggest that a low dose of adenoviral vector soaked in GSP substantially augments transduction efficiency to hepatocytes with only a mild effect on liver function. Although the underlying mechanism is not clear, increased contact time and decreased clearance rate of the adenoviral vector inside the liver might be responsible for the observed high transduction efficiency.
Chronological transgene expressions are different for CHAE-and CHAS-mediated adenoviral vector deliveries
As the clearance rate of CHAE-mediated adenovirus delivery might be lower than that of CHAS-mediated delivery, we chronologically quantified transgene expression. As liver biopsy specimens of different lobes should be used for evaluation of temporal gene expression after Ad.LacZ delivery, Ad.hHGF (8 Â 10 expression. Thus, serum human HGF (hHGF) concentration can be measured as HGF is a secretory protein.
The serum level of hHGF after delivery of Ad.hHGF by CHAE was significantly lower on days 1 and 3, but significantly higher on days 7, 14, 21, and 28 (Fig 3a) . This suggests that both the onset time and the duration of adenoviral gene expression are greater after CHAEmediated delivery. The underlying mechanism for delayed increase of serum hHGF in the CHAE group needs to be illuminated in a future study. We speculate that timedependent decrease of Kupffer cell activity due to phagocytosis of GSP 13, 14 and/or extremely abundant transgene expression in localized areas after GSPmediated adenovirus delivery (Fig 2l) , might be involved in the delayed increase of hHGF. However, as we cannot exclude the possibility that decreased clearance rate of HGF in GSP-injected animal were due to crossreactivity between human and canine HGF, a hepatic arterial embolization technique with Ad.hHGF soaked in GSP in a rat model was used, as Quantkine s can differentiate rat HGF from human HGF. Comparison of Figure 2b and c shows that both the onset time and the duration of adenoviral gene expression are greater in the case of adenoviral injection with GSP, which is a similar pattern to those after CHAE is done in a canine. Figure 3c shows that 5 Â 10 11 particles/kg of Ad.hHGF without GSP could not increase the detectable level of serum hHGF, but the same dose of Ad.hHGF with GSP produced a relatively high concentration. More interestingly, the duration of transgene expression after injection with a low dose (10 12 particles/kg) of Ad.hHGF with GSP is longer than that after injection of a high dose (5 Â 10 12 particles/kg), suggesting that immunological activation by high dose adenovirus might be involved in differential kinetic transgene expression. The underlying mechanism for differential transgene expression pattern after injection with differential doses of Ad.hHGF with GSP needs to be illuminated in a future study. There was a report that adenoviral mixture with an IOE increased the efficiency of transduction into HCC. 15 As IOE has frequently been combined with GSP during classical chemoembolization for human HCC treatment, 14, 16 we can expect that the combination of IOE and GSP for adenoviral mixture might increase the transduction efficiency even further. However, homogenous and widespread embolization after combined application of IOE and GSP could also increase the toxicity. 14 Further research regarding IOE and/or GSP might be needed to address the question of an optimal condition of viral delivery using transcutaneous arterial embolization.
Although this study raises additional questions, the results show the possibility of clinical application in combined therapy for human HCC using oncolytic adenovirus and anticancer agents soaked in GSP.
